Oncolytics Biotech, Inc. (ONCY)
0.85
+0.01
(+1.41%)
USD |
NASDAQ |
Sep 01, 13:36
Oncolytics Biotech Cash and Short Term Investments (Quarterly) : 4.115M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.115M |
| March 31, 2026 | 5.493M |
| December 31, 2025 | 5.202M |
| September 30, 2025 | 8.873M |
| June 30, 2025 | 10.72M |
| March 31, 2025 | 10.63M |
| December 31, 2024 | 11.08M |
| September 30, 2024 | 14.51M |
| June 30, 2024 | 18.16M |
| March 31, 2024 | 21.88M |
| December 31, 2023 | 26.48M |
| September 30, 2023 | 29.57M |
| June 30, 2023 | 18.40M |
| March 31, 2023 | 21.92M |
| December 31, 2022 | 23.72M |
| September 30, 2022 | 23.55M |
| June 30, 2022 | 26.12M |
| March 31, 2022 | 31.61M |
| December 31, 2021 | 32.67M |
| September 30, 2021 | 37.96M |
| June 30, 2021 | 41.02M |
| March 31, 2021 | 40.07M |
| December 31, 2020 | 24.51M |
| September 30, 2020 | 20.00M |
| June 30, 2020 | 21.96M |
| Date | Value |
|---|---|
| March 31, 2020 | 21.48M |
| December 31, 2019 | 10.91M |
| September 30, 2019 | 9.289M |
| June 30, 2019 | 9.394M |
| March 31, 2019 | 10.64M |
| December 31, 2018 | 10.03M |
| September 30, 2018 | 12.54M |
| June 30, 2018 | 14.25M |
| March 31, 2018 | 6.008M |
| December 31, 2017 | 9.447M |
| September 30, 2017 | 11.22M |
| June 30, 2017 | 12.84M |
| March 31, 2017 | 7.575M |
| December 31, 2016 | 10.53M |
| September 30, 2016 | 13.47M |
| June 30, 2016 | 15.72M |
| March 31, 2016 | 17.26M |
| December 31, 2015 | 18.77M |
| September 30, 2015 | 22.39M |
| June 30, 2015 | 25.70M |
| March 31, 2015 | 24.19M |
| December 31, 2014 | 13.97M |
| September 30, 2014 | 15.25M |
| June 30, 2014 | 17.76M |
| March 31, 2014 | 20.10M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Sangamo Therapeutics, Inc. | 27.59M |
| Sarepta Therapeutics, Inc. | 788.49M |
| Anixa Biosciences, Inc. | 13.69M |
| Vicapsys Life Sciences, Inc. | 0.1325M |